Anticorps Monoclonal anti-P27; KIP1
P27; KIP1 Monoclonal Antibody for WB, Indirect ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, rat, souris
Applications
WB, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
3F12C10
N° de cat : 67355-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
67355-1-PBS cible P27; KIP1 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | P27; KIP1 Protéine recombinante Ag14634 |
Nom complet | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
Masse moléculaire calculée | 198 aa, 22 kDa |
Poids moléculaire observé | 27 kDa |
Numéro d’acquisition GenBank | BC001971 |
Symbole du gène | p27 Kip1/CDKN1B |
Identification du gène (NCBI) | 1027 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
DKN1B, also named as P27 or KIP1, is a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. P27 binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controlling cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Downregulation of P27 has been implicated in the progression of several malignancies, including lung cancer, hepatocellular carcinoma, salivary cancer, oral squamous cell carcinomas, and gastric cancer.